1. Akin MR, Nguyen GK. Fine-needle aspiration biopsy cytology of hyalinizing trabecular adenomas of the thyroid. Diagn Cytopathol. 1999; 20:90–4.
Article
2. Lee S, Han BK, Ko EY, Oh YL, Choe JH, Shin JH. The ultrasonography features of hyalinizing trabecular tumor of the thyroid are more consistent with its benign behavior than cytology or frozen section readings. Thyroid. 2011; 21:253–9.
Article
3. Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol. 2008; 32:1877–89.
Article
4. Nga ME, Lim GS, Soh CH, Kumarasinghe MP. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma. Diagn Cytopathol. 2008; 36:550–6.
Article
5. Carney JA, Ryan J, Goellner JR. Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 1987; 11:583–91.
Article
6. Bishop JA, Ali SZ. Hyalinizing trabecular adenoma of the thyroid gland. Diagn Cytopathol. 2011; 39:306–10.
Article
7. Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. Am J Surg Pathol. 2004; 28:859–67.
8. Hirokawa M, Carney JA, Ohtsuki Y. Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol. 2000; 24:877–81.
Article
9. Evenson A, Mowschenson P, Wang H, Connolly J, Mendrinos S, Parangi S, et al. Hyalinizing trabecular adenoma–an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am J Surg. 2007; 193:707–12.
Article
10. Shikama Y, Osawa T, Yagihashi N, Kurotaki H, Yagihashi S. Neuroendocrine differentiation in hyalinizing trabecular tumor of the thyroid. Virchows Arch. 2003; 443:792–6.
Article
11. Gaffney RL, Carney JA, Sebo TJ, Erickson LA, Volante M, Papotti M, et al. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol. 2003; 27:494–8.
Article
12. Ünlütürk U, Karaveli G, Sak SD, Erdoğan MF. Hyalinizing trabecular tumor in a background of lymphocytic thyroiditis: a challenging neoplasm of the thyroid. Endocr Pract. 2011; 17:e140–3.
Article
13. Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 2000; 24:575–8.
Article
14. Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland identification through MIB-1 staining of fine-needle aspiration biopsy smears. Am J Clin Pathol. 2004; 122:506–10.
15. Kim T, Oh YL, Kim KM, Shin JH. Diagnostic dilemmas of hyalinizing trabecular tumours on fine needle aspiration cytology: a study of seven cases with BRAF mutation analysis. Cytopathology. 2011; 22:407–13.
Article
16. Baloch ZW, Puttaswamy K, Brose M, LiVolsi VA. Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal. 2006; 3:17.
17. Nakamura N, Carney JA, Jin L, Kajita S, Pallares J, Zhang H, et al. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Invest. 2005; 85:1065–75.
Article
18. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005; 12:245–62.
Article